drugset
drugset / Trial / NCT03085836

A Pharmacokinetic Study of TAK-438 in Healthy Adult Chinese Participants

NCT03085836 ↗

Phase 1 Completed 33 enrolled Takeda
Non-randomizedParallel-groupOpen-labelOther

Summary

The purpose of this study is to determine the pharmacokinetics (PK) of TAK-438 in healthy adult Chinese participants after both single and multiple dose administration.

Timeline

Start
2017-04-19
Primary completion
2017-08-17
Completion
2017-08-17

Drugs

EvaluationDrugModalityDoseRoute
Subject Vonoprazan Other / unclassified 10 mg Oral
Subject Vonoprazan Other / unclassified 20 mg Oral

Indications

No indication recorded.